Keywords
How to Cite
Abstract
The data on radiosurgical treatment of 97 (50 men and 47 women) patients with metastatic brain lesion are presented. At the time of radiosurgical treatment the control over extracranial foci was in 44 patients. According to ECOG- WHO the general status of patients was assessed as 0-1in 70, as 2 in 20 and as 3-4 in 7 cases. The most common sources of metastatic tumors were lung, breast and skin melanoma. The vast majority of patients had from 1 to 4 foci of brain lesions. Median overall survival in patients with metastatic brain damage after radiosurgical treatment was 10.5 months. The median time to progression in the brain was 5,3 months. Both parameters significantly depended on the type of primary tumor. They were the worst for renal cell carcinoma and small cell lung cancer, slightly higher for skin melanoma and non-small cell lung cancer and the highest for the group of tumors of other locations. Overall survival was significantly reduced from 47% to 35% in the absence of the control over the extracranial foci. It practically was independent of whether one or more brain lesions were in a patient. The time to progression in the brain was unreliable greater in solitary foci.References
Andrews D.W., Scott C.B., Sperduto P.W. et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial // Lancet. - 2004. - Vol. 363. - P. 1665-1672.
Borgelt B., Gelber R., Larson M. et al. Ultra-rapid high dose irradiation schedules for the palliation of brain me tastases: final results of the first two studies by the Radiation Therapy Oncology Group // Int. J. Radiat. Oncol. Biol Phys. - 1981. - Vol. 7. - P. 1633-1638.
Borgelt В., Gelber R., Kramer S. et al. The palliation of brain metastases; final results of the first two studies by the Radiation Therapy Oncology Group // Int. J. Radiat. Oncol. Biol. Phys. -1980. - Vol. 6. - P. 1-9.
Chang E.L., Wefel J.S., Hess K. et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain irradiation: a randomized controlled trial // Lancet. Oncol. - 2009. - Vol. 10. - P. 1037-1044.
Chidel M.A., Suh J.H., Reddy C.A. et al. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases // Int. J. Radiat. Oncol. Biol. Phys. - 2000. - Vol. 47. - P. 993-999.
Coia L.R. The role of radiation therapy in the treatment of brain metastases // Int. J.Radiat. Oncol. Biol. Phys. -1992. - Vol. 23. - P. 229-238.
Herfarth K.K., Izwekowa O., Thilmann C. et al. LINAC-based radiosurgery of cerebral melanoma metastases: analysis of 122 metastases treated in 64 patients// Strahlenther. Onkol. - 2003. - Vol. 179. - P. 366-371.
Hindo W.A., DeTrana F.A.3rd., Lee M.S. et al. Large dose increment irradiation in treatment of cerebral metastases // Cancer. - 1970. - Vol. 26. - P. 138-141.
Karlsson B., Hanssens P., Wolff R. et al. Thirty years’ experience with Gamma Knife surgery for metastases to the brain // J. Neurosurg. - 2009. - Vol. 111. - P. 449-457.
Kondziolka D., Kano H., Harrison G.L. et al. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer // J. Neurosurg. - 2011. - Vol. 114. - P. 792-800.
Kondziolka D., Patel A., Lunsford L.D. et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases // Int. J. Radiat. Oncol. Biol. Phys. - 1999. - Vol. 45. - P. 427-434.
Kurtz J.M., Gelber R., Brady L.W. et al. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group // Int. J. Radiat. Oncol. Biol. Phys. -1981. - Vol. 7. - P. 891-895.
Liew D.N., Kano H., Kondziolka D. et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases // J. Neurosurg. - 2011. - Vol. 114. - P. 769-779.
Linskey M.E., Andrews D.W., Asher A.L. et al. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guide- 25 line // J. Neurooncol. - 2010. - Vol. 96. - P. 45-68.
Matsunaga S., Shuto T., Kawahara N. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype // J. Neurosurg. - 2010. - Vol. 113 (suppl). - P. 65-72.
Mintz A.P., Cairncross J.G. Treatment of a single brain metastasis: the role of radiation following surgical resection // JAMA. - 1998. - Vol. 280. - P 1527-1529.
Muacevic A., Kreth F.W., Mack A. et al. Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma // Minim. Invasive. Neurosurg. - 2004. - Vol. 47. - P. 203-208.
Murray K.J., Scott C., Greenberg H.M. et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104 // Int. J. Radiat. Oncol. Biol. Phys. - 1997. - Vol. 39. - P. 571-574.
Nieder C., Berberich W., Schnabel K. Tumor-related prognostic factors for remission of brain metastases after radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. - 1997. - Vol. 39. - P. 25-30.
Nieder C., Nestle U., Walter K. et al. Dose/effect relationships for brain metastases // J. Cancer. Res. Clin. Oncol. - 1998. - Vol. 124. - P. 346-350.
Patchell R.A., Tibbs P.A., Regine W.F. et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial // JAMA. - 1998. - Vol. 280. - P. 1485-1489.
Patchell R.A., Tibbs P.A., Walsh J.W. et al. A randomized trial of surgery in the treatment of single metastases to the brain // N. Engl. J. Med. - 1990. - Vol. 322. - P. 494-500.
Percy A.K., Elveback L.R., Okazaki H., Kurland L.T. Neoplasms of the central nervous system: epidemiologic considerations // Neurology. - 1972. - Vol. 22. - P. 40-48.
Pirzkall A., Debus J., Lohr F. et al: Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases // J. Clin. Oncol. - 1998. - Vol.16. - P. 3563-3569.
Sawaya R., Bindal R.K., Lang F.F. et al. Metastatic Brain Tumors, ed 2. New York, Churchill - Livingstone, 2001
Sawaya R., Ligon B.L., Bindal R.K. Management of metastatic brain tumors // Ann. Surg. Oncol. - 1994. - Vol. 1. - P. 169-178.
Serizawa T., Hirai T., Nagano O. et al. Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of case meeting the Japanese prospective multi-institutiona! study (JLGK0901) inclusion criteria // J. Neurooncol. - 2010. - Vol. 98. - P. 163-167.
E. Shaw, C. Scott, L. Souhami et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases; final report of RTOG protocol 90-05 // Int. J. Radiat. Oncol. Biol. Phys. - 2000. - Vol. 47. - P. 291-298.
Sheehan J.P., Sun M.H., Kondziolka D. et al. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control // J. Neurosurg. - 2003. - Vol. 98. - P. 342-349.
Sneed P.K., Lamborn K.R., Forstner J.M. et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? // Int. J. Radiat. Oncol. Biol. Phys. - 1999. - Vol. 43. - P. 549-558.
Vecht C.J., Haaxma-Reiche H., Noordijk E.M. et al: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? // Ann. Neurol. - 1993. -Vol. 33. - P. 583-590.
Wang LG, Guo Y, Zhang X. et al. Brain metastasis; experience of the Xi-Jing hospital // Stereotact. Funct. Neurosurg. - 2002. - Vol. 78. - P. 70-83.
Young D.F., Posner J.B., Chu F. et al. Rapid-course radiation therapy of cerebral metastases: results and complications // Cancer. - 1974. - Vol. 34. - P. 1069-1076.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...